AGP Executive Report

Global Health: Berlin’s World Health Summit put a strained global health system in focus, with leaders pressing for stronger local medicine production and universal coverage. Germany also plans more support for pharmaceutical production in Africa. Medical Innovation: Germany has treated its first patient with CRISPR therapy since the treatment’s approval, a milestone for gene-editing care. Food Safety: A cyberattack that overheated refrigeration systems at French supermarkets may have affected Germany and other European countries, raising concerns about food safety and supply chains. Research: The 2026 Nobel Prize in Medicine recognized optogenetics, which uses light to control brain cells.

Long COVID: A new study links weaker handgrip strength and faster muscle fatigue with more severe post-COVID symptoms. Researchers say grip testing may offer clues to muscle problems, but it is not a diagnostic test. German Pharma: The US FDA approved pritelivir, developed by Germany’s AiCuris, for persistent herpes lesions in immunocompromised adults who do not respond to standard antivirals. In a trial, lesions healed by day 28 in about 63% of patients taking the drug, versus 34% on comparison treatments. Gene Therapy: Germany has treated its first patient with CRISPR therapy since the treatment’s approval, marking a milestone for access to gene-editing care. Global Health: Germany plans to increase support for African drug and vaccine makers, aiming to strengthen local production. The issue was also in focus at the World Health Summit in Berlin, as coverage warned that the global health system is under growing strain.

Global Health: Berlin hosted the 2026 World Health Summit as leaders confronted pressure on health systems and funding. Infectious Diseases: France reported 161 locally acquired West Nile virus cases this season, including 60 neuro-invasive cases and five deaths; officials said it is unclear whether the deaths were caused by the virus. Gene Therapy: Germany has treated its first patient with CRISPR therapy since the treatment’s approval. Access to Medicines: Germany plans to increase support for African drug and vaccine makers, aiming to strengthen local production.

Metabolic Health: Researchers at Germany’s DIfE found a blood-fat signature linked to peanut consumption was associated with lower type 2 diabetes risk. The study does not show that peanuts prevent the disease. Gene Therapy: Germany has treated its first patient with CRISPR therapy since approval, marking a milestone for the country’s use of gene-editing medicine. Global Health: At Berlin’s World Health Summit, leaders warned that funding shortfalls are putting pressure on health systems worldwide. Elderly Care: Germany’s planned reforms have drawn criticism that they could worsen the care sector’s existing crisis. Medicine Production: Germany is planning more support for African drug and vaccine manufacturers, aiming to strengthen local production.

Global Health: At Berlin’s World Health Summit, leaders faced a health system under growing financial strain. A new Lancet assessment warns that nuclear conflict and malicious AI pose low-probability, extinction-level risks, alongside climate change and childhood malnutrition. Medical Advances: Germany has treated its first patient with CRISPR therapy since approval. The 2026 medicine Nobel, shared by two German scientists and a US colleague, recognized research that uses light to control nerve cells. Prevention & Policy: Europe is debating whether tougher nicotine rules can curb smoking without fuelling illicit sales. A German study found carnivore dieters’ LDL cholesterol rose by nearly 100 points; a new review does not endorse the diet long term.

Global Health: The World Health Summit opens in Berlin on October 11, as organizers warn that development aid fell 23% in 2025, with Germany among the major donors cutting budgets. Sessions will focus on health-system funding, pandemic readiness, AI and workforce needs. Nutrition Research: A German study found LDL cholesterol rose by nearly 100 points among carnivore dieters; a 2026 review does not endorse the diet long term. Military Medicine: Doctors at the US military hospital in Landstuhl treated a service member whose severely injured limb had turned nearly black after a week without access to US-run care, highlighting gaps in casualty treatment. Nobel Research: German scientists Peter Hegemann and Georg Nagel shared the 2026 Medicine Nobel with Karl Deisseroth for work that enabled optogenetics, a technique using light to control nerve-cell activity.

Vaccines and the Gut: A study involving more than 170 people linked stronger fever after COVID vaccination with gut bacteria producing more flagellin and signs of gut inflammation. The findings point to a possible role for the microbiome in vaccine reactions, but do not establish cause and effect. Prostate Cancer Care: A study spanning Germany, the Netherlands and the US found that combining MRI readings with AI risk assessments could have avoided nearly 19% of biopsies while retaining 98.4% sensitivity for significant cancer. German Medical Research: Germany has treated its first patient with CRISPR therapy since the treatment’s approval, marking a milestone for gene-based care. Medtech Industry: German-owned B. Braun plans to wind down its US interventional-device division, with sales expected to continue into early 2027.**

Gene Therapy: Germany has treated its first patient with CRISPR therapy since the treatment was approved, marking a step from gene-editing research toward clinical care. Brain Research: German scientists Peter Hegemann and Georg Nagel shared the 2026 Nobel Prize in Medicine for work that made it possible to control nerve cells with light, a tool for studying brain activity. Childhood Obesity: WHO advises against weight-loss drugs for young children with obesity.

Childhood Obesity: The WHO advises against weight-loss drugs for young children with obesity, a caution with implications for families and clinicians in Germany as well as worldwide. Drug Access: A Dutch court has barred sales of subcutaneous Keytruda in eight European countries, adding uncertainty around access to a widely used cancer treatment. Gene Therapy: Germany has treated its first patient with CRISPR therapy since the treatment was approved, marking a milestone for advanced care. Brain Research: German scientists Peter Hegemann and Georg Nagel shared the 2026 Nobel Prize in Medicine with US researcher Karl Deisseroth for work that enabled nerve cells to be controlled with light. Elder Care: A report warns that the German government’s reform plans could deepen the country’s elderly-care crisis.

Outbreak Preparedness: Europe’s window to prepare for mosquito-borne disease is narrowing, a Heidelberg-affiliated researcher warns. Tiger mosquitoes are spreading north, and locally transmitted dengue and chikungunya outbreaks are advancing even faster. Child Health: WHO has issued new guidelines to tackle rising childhood obesity, while experts debate how best to discuss obesity beyond BMI. Medical Breakthroughs: Germany has treated its first patient with CRISPR therapy since the treatment was approved. German researchers Peter Hegemann and Georg Nagel also shared the 2026 Nobel Prize in Medicine for work that helped make it possible to control nerve cells with light.

Gene Therapy: Charité in Berlin says a 19-year-old with beta-thalassaemia is the first patient in Germany treated with the approved CRISPR-based drug Casgevy. He no longer needs regular blood transfusions and is recovering well. German Research: Two German scientists, Peter Hegemann and Georg Nagel, shared the 2026 Nobel Prize in Medicine with Stanford’s Karl Deisseroth for pioneering optogenetics, which uses light to control nerve cells and has opened new ways to study the brain. Medicine Access: Germany’s Health Ministry says a reported shortage of thyroid medication in pharmacies is temporary.

Nobel Medicine & Brain Research: A US-German trio won the 2026 Nobel Prize in Physiology or Medicine for optogenetics—using light to switch nerve cells on and off—highlighting a major step for understanding brain disorders and improving future therapies. Stroke Monitoring Breakthrough: German-linked researchers reported graphene-based sensors that can record slow electrical changes in the brain after ischemic stroke, helping distinguish healthy tissue from areas at risk or already severely damaged. EU Health Policy: Belgium’s health minister urged the EU to investigate the US over “unlawful coercion” affecting Europe’s healthcare model, arguing compulsory insurance is built on solidarity rather than individual risk. Rare Disease & Nuclear Medicine Updates: ITM Isotope Technologies Munich and Lumara Bio announced new EANM Congress presentations for radiopharmaceuticals, including ¹⁷⁷Lu-edotreotide and Ga-DPI-4452 imaging work in cancer. Infectious Disease Alert: A West Nile virus outbreak is being reported across 16 European countries, with warnings to take mosquito-bite prevention seriously.

Nobel Medicine Breakthrough: A US-German trio won the 2026 Nobel Prize in Physiology or Medicine for optogenetics—using light to switch nerve cells on and off—highlighting a major step toward more precise brain and disease research. Clinical Research & Care: A Serbian registry study reports that biological sex measurably changes how myotonic dystrophy affects multiple organ systems, suggesting sex-specific monitoring and risk planning. Digital Health at MEDICA: MEDICA 2026 in Düsseldorf will debut a new Digital Health Stage focused on practical integration of AI, robotics, cloud tools, and cybersecurity into everyday care. Urology Access: In The Bahamas, a urologist performed GreenLight photovaporization for obstructive benign prostate enlargement for the first time locally—training rooted in Hamburg, Germany. Public Health Watch: Russia’s Irkutsk anti-plague institute death case is prompting conflicting explanations and large contact monitoring, raising concerns about transparency as global health officials watch for spread. Safety & Mental Health: A Lufthansa passenger was arrested after allegedly trying to open an aircraft door mid-flight; police said he was taken to a psychiatric hospital due to his condition.

Nobel Medicine: The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth (US) and German researchers Peter Hegemann and Georg Nagel for optogenetics—using light to switch brain cells on and off—opening new ways to study neural circuits and disease. German Health Tech & Devices: Smith+Nephew launched its CARTIHEAL AGILI-C cartilage repair implant in Europe, following US approval and multi-year trial results showing improved knee outcomes versus standard care. AI Privacy in Germany: German regulators warn that OpenAI plans personalized ads in ChatGPT for Europe, using past chats and device/usage data—raising concerns about sensitive personal information. Cybersecurity & Health Data Risk: ASOS is investigating after app users received a message claiming attackers “fully compromised” a Snowflake instance, highlighting how cloud data breaches can quickly become public extortion. Infectious Disease Update: Mpox is still spreading at low levels in the US; guidance covers who should get the JYNNEOS vaccine and how protection varies. Healthcare Access & Costs: US policy moves include Medicare and ACA checks, but experts say they may not offset rising healthcare expenses. Water & Health: Kabul is on track to run out of water by 2030, with major knock-on risks for hygiene and disease.

Nobel for Optogenetics: The 2026 Nobel Prize in Physiology or Medicine went to US scientist Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel for optogenetics—using light to switch specific nerve cells on and off—opening new ways to map brain circuits and potentially advance treatments for disorders like Parkinson’s, epilepsy, depression, and vision loss. Travel-Linked Illness (Germany): A 39-year-old woman in a German emergency department presented with high fever, severe headache, and lab signs of hemolysis and liver involvement after a rural Vietnam trip, with clinicians still working to identify the infection source. Public Health & Weight Management: A new study on switching to oral semaglutide reports about 4.1% weight loss at 3 months and 40.7% reaching at least 5% loss, adding real-world interest in GLP-1 options. Care Reform (Germany): Germany has agreed on elder care reform after protracted talks, aiming to reshape how long-term support is delivered. Safety & Emergency Care (Germany/Europe): Reports highlight ongoing concerns about medical readiness after war-related attacks, including claims of delayed or inadequate treatment for wounded soldiers.

Nobel Medicine: The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth (US) and Germans Peter Hegemann and Georg Nagel for optogenetics—using light to switch specific nerve cells on and off—advancing brain research and offering hope for treatments such as restoring vision. Nutrition & Longevity: A Leipzig-based cohort study in Nutrients found poor nutritional status can predict higher mortality risk even among people who are overweight, suggesting BMI alone can miss hidden risk. German Health Tech & Diabetes: Sernova and Seraxis closed a US$11.2m financing tied to a merger forming BetaNova, aiming to push type 1 diabetes cell therapy toward a near-term Phase 1/2 trial. Privacy & Wearables: Norway is seeking a temporary ban on smart glasses in some settings over privacy concerns—an issue likely to resonate with Germany’s health and care tech users. Military Care Scrutiny: Reporting on a deadly Iranian drone strike in Kuwait highlights soldiers’ claims of medical system failures, raising questions about emergency care readiness.